What’s next in oncology: Research breakthroughs from the 2025 ASCO® annual meeting

Explore key research and clinical insights from the 2025 ASCO® Annual Meeting, featuring expert analysis from Drs. Ezra Cohen, Sara Tolaney, Nataliya Uboha, and Cynthia Ma.

Aug 14, 2025

Providers

Webinar

Ezra CohenChief Medical Officer of Oncology, Tempus,

Cynthia X. Ma, MD, PhDProfessor, Medicine, Division of Oncology at Washington University School of Medicine

Nataliya Uboha, MD, PhDFaculty Leader for Early Phase Oncology Therapeutics Program, Associate Professor, Department of Medicine, Section of Hematology & Oncology, University of Wisconsin

Sara TolaneyChief of the Division of Breast Oncology at Dana-Farber Cancer Institute, Associate Professor of Medicine at Harvard Medical School

Session Highlights

A cross-functional discussion on what's next in oncology, driven by the latest innovations shaping cancer care
Breakthrough research from the 2025 ASCO® Annual Meeting, featuring new clinical data from: SERENA-6, DESTINY-Breast09 and MATTERHORN
Insights from Tempus' own ASCO presentation, including new data from the xM MRD assay
A look at the evolving role of precision medicine in oncology